STOCKWATCH
·
Pharmaceuticals
Acquisitions30 Dec 2025, 04:30 pm

Lupin's Acquisition of VISUfarma B.V. Progressing, Expected to Close by February 2026

AI Summary

Lupin Ltd. has updated the progress of its acquisition of VISUfarma B.V., a Netherlands-based company. The acquisition was initially agreed upon in September 2025, with the expectation of completion by the end of 2025. However, due to certain closing conditions, the transaction is now expected to be finalized by February 28, 2026.

Key Highlights

  • Lupin's subsidiary, Nanomi B.V., agreed to acquire VISUfarma B.V. in September 2025.
  • The acquisition is expected to complete by February 28, 2026, subject to closing conditions.
  • The transaction was initially planned to close by the end of 2025.
LUPIN
Pharmaceuticals
LUPIN LTD.

Price Impact